Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable podcast. CIT can also broadcast NIH-only or HHS-only content.

Bringing Therapeutic Cancer Vaccines and Immunotherapies Through Development to Licensure (Day 1)

Loading video...

 
   
Air date: Thursday, February 08, 2007, 8:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views:
Category: Conferences
Runtime: 08:23:11
Description: A variety of promising cancer vaccines and immunotherapies are in the pipeline, but they must travel down a rigorous scientific and licensing pathway. Plan now to attend this workshop, cosponsored by FDA and NCI, to learn from experts in government, industry, and academia about what is needed to bring cancer vaccines and immunotherapies through development and clinical trials to licensure.

This workshop is ideal for researchers and representatives of biotechnology and pharmaceutical companies who are involved in product development and preparation for licensure. Individuals and companies will gain important insights into the efficient development of cancer vaccines and how to avoid development pitfalls. The workshop is also an opportunity for industry to provide feedback to regulatory agencies.

For more information, visit
https://cms.palladianpartners.com/cms/1156354418/home.htm
Debug: Show Debug
NLM Title: Bringing therapeutic cancer vaccines and immunotherapies through development to licensure [electronic resource] / NCI and FDA.
Author: National Cancer Institute (U.S.)
Publisher:
Abstract: (CIT): A variety of promising cancer vaccines and immunotherapies are in the pipeline, but they must travel down a rigorous scientific and licensing pathway. Plan now to attend this workshop, cosponsored by FDA and NCI, to learn from experts in government, industry, and academia about what is needed to bring cancer vaccines and immunotherapies through development and clinical trials to licensure. This workshop is ideal for researchers and representatives of biotechnology and pharmaceutical companies who are involved in product development and preparation for licensure. Individuals and companies will gain important insights into the efficient development of cancer vaccines and how to avoid development pitfalls. The workshop is also an opportunity for industry to provide feedback to regulatory agencies.
Subjects: Cancer Vaccines
Drug Design
Immunotherapy
Licensure, Pharmacy
Neoplasms--immunology
Neoplasms--therapy
Publication Types: Lectures
Webcasts
Download: To download this event, select one of the available bitrates:
[384k]    How to download a Videocast
NLM Classification: QZ 266
NLM ID: 101306041
CIT Live ID: 5542
Permanent link: http://videocast.nih.gov/launch.asp?13629